第三届董事会第二次会议决议公告 证券代码：301339 证券简称：通行宝 公告编号：2025-063 江苏通行宝智慧交通科技股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或者重大遗漏。 一、董事会会议召开情况 江苏通行宝智慧交通科技股份有限公司（以下简称"公司"）第三届董事会第二 次会议通知已于2025年12月26日以邮件方式向全体董事发出，并于2025年12月30日以 现场及通讯会议的形式召开。本次会议应出席董事9人，实际出席董事9人。本次会议 由董事长王明文先生主持，公司高级管理人员列席了会议。本次会议的召开和表决程 序符合《中华人民共和国公司法》等法律、法规和《公司章程》的规定。 二、董事会会议审议情况 经与会董事认真审议，充分讨论，会议审议并通过了如下议案： （一）审议通过《关于感动科技整体变更为股份有限公司的议案》 经全体董事审议，同意控股子公司南京感动科技有限公司进行股份制改制，由 有限责任公司整体变更为股份有限公司。 具体内容详见公司同日披露于巨潮资讯网（www.cninfo.com.cn）的相关公告。 表决结果：9票同意、0票反对、0票弃权。 ...

证券代码：301339 证券简称：通行宝 公告编号：2025-064 1 一、概述 感动科技成立于2005年11月，核心业务为智慧交通领域的软件开发、系统集成 及智能设备研发，系国家级专精特新重点"小巨人"企业、国家高新技术企业。感 动科技以"赋能智慧交通数字化转型"为核心定位，专注于交通智能体开发、云指 挥调度平台建设及智慧路网系统集成，为客户提供从"技术研发-软件输出-场景落地" 的全链条服务。 为进一步完善公司治理结构，提升规范运作水平，感动科技将进行股份制改制 并整体变更为股份有限公司。本次控股子公司股份制改制事项在公司董事会审批权 限范围内，无需提交公司股东会审议。本事项不构成关联交易，不构成《上市公司 重大资产重组管理办法》规定的重大资产重组。 二、感动科技基本情况 （一）基本信息 公司名称：南京感动科技有限公司 统一社会信用代码：9132010478066582XA 注册地址：南京市秦淮区菱角市66号39栋102室 法定代表人：王明文 注册资本：3,000万元 成立日期：2005年11月23日 江苏通行宝智慧交通科技股份有限公司 关于控股子公司进行股份制改制的公告 本公司及董事会全体成员保证信息 ...

Group 1 - The core viewpoint of the article highlights that Tongxingbao (301339.SZ) has developed smart unmanned vehicle equipment capable of multiple applications, including urban road cleaning, express delivery, and scenic area sightseeing [1] - The company has achieved small-scale commercialization of some of its products [1]

Group 1 - The core viewpoint of the article is that Tongxingbao (301339.SZ) has not yet commercialized its products and technologies in the low-altitude economy and drone sectors [1]

Group 1 - Guangqi Technology's controlling shareholder proposed a share buyback of 50 million to 100 million yuan for employee stock ownership plans or equity incentives [1] - Xingyuan Zhuomai received a supplier designation from a domestic electric vehicle manufacturer to develop and supply reducer shell components, with expected sales of approximately 575 million yuan over four years from 2027 to 2030 [2] - Weigao Bio's application for clinical trials of subcutaneous human immunoglobulin has been accepted by the National Medical Products Administration, targeting primary immunodeficiency diseases [3] Group 2 - Hongda Electronics disclosed uncertainty regarding the IPO progress of its associate Jiangsu Zhanxin, in which it holds a 13.79% stake [4] - Kangchen Pharmaceutical received FDA approval to conduct clinical trials for its KC1086 project, aimed at treating advanced recurrent or metastatic solid tumors [5] - Kweichow Moutai adjusted its share buyback price ceiling to 1863.67 yuan per share, effective from December 19, 2025 [6] Group 3 - Mousse Co. announced that its controlling shareholder and actual controllers committed not to reduce their holdings within one year [7] - Tongxingbao's subsidiary signed a business contract worth 43.166 million yuan for a cloud expansion project [8] - Kaifa Electric announced plans for three shareholders to collectively reduce their holdings by 0.6999% [9] Group 4 - Longpan Technology plans to increase the production capacity of lithium iron phosphate cathode materials from 62,500 tons per year to 100,000 tons per year [10] - Zhuhai Guanyu announced plans for two shareholders to reduce their holdings by up to 3% [11] - Jiaheng Home Textiles is planning a change in control, leading to a temporary suspension of its stock [12] Group 5 - Kehua Bio's subsidiary received a medical device registration certificate for a gene polymorphism detection kit [13] - Saitex New Materials' actual controller plans to reduce holdings by up to 3% [14] - Sanhui Electric announced a shareholder's plan to reduce holdings by up to 2% [15] Group 6 - Binhua Co. plans to establish a venture capital fund with a total scale of 400 million yuan, focusing on strategic emerging industries [16] - Jindun Co. announced plans for two shareholders to reduce their holdings by up to 4% [17] - Hengdian East Magnetic's controlling shareholder plans to reduce holdings by up to 1% [18][19] Group 7 - Luxin Investment's controlling shareholder plans to reduce holdings by up to 1% [20] - Huakang Clean announced a joint bid for a hospital procurement project worth 157 million yuan [21] - Xuedilong plans to reduce its repurchased shares by up to 488,560 shares [22] Group 8 - Enhua Pharmaceutical's subsidiary signed an exclusive commercial cooperation agreement for three long-acting antipsychotic products [23] - Aier Eye Hospital plans to acquire partial equity in 39 institutions for a total of 963 million yuan [24] - Gaozheng Mining plans to acquire 100% equity of Overseas Explosives for 510 million yuan [25] Group 9 - Donghong Co. plans to repurchase shares worth 30 million to 60 million yuan for employee stock ownership plans [26] - Bear Electric's controlling shareholder plans to reduce holdings by up to 0.64% [27] - *ST Zhengping announced the initiation of pre-restructuring by the Xining Intermediate Court [28][29] Group 10 - Caesar Travel's shareholder plans to reduce holdings by up to 3% [30] - Lianchuang Electronics announced a change in controlling shareholder to Jiangxi State-owned Assets Supervision and Administration Commission [31] - Beixin Road and Bridge plans to transfer 5.33% equity in Henan Yuhang for 243 million yuan [32] Group 11 - Fenglong Co. is planning a change in control, with stock resuming trading [33]

Core Viewpoint - The company, 通行宝, has been awarded a contract for the Jiangsu Expressway Cloud Expansion Project 2025, indicating a significant business opportunity and growth potential in the smart transportation sector [1] Group 1: Contract Details - Jiangsu Expressway Network Operation Management Co., Ltd. has selected the company's subsidiary, 南京感动科技有限公司, as the successful bidder for the project [1] - The contract amount for the Jiangsu Expressway Cloud Expansion Project is 43.166 million RMB [1] Group 2: Business Implications - This contract is categorized as a routine operational contract for the company, suggesting stability in its revenue stream [1]

Core Viewpoint - The company, 通行宝, has been awarded a contract for the Jiangsu Expressway Cloud Expansion Project 2025, indicating a significant business opportunity in the transportation technology sector [1] Group 1: Contract Details - Jiangsu Expressway Network Operation Management Co., Ltd. has selected the company's subsidiary, 南京感动科技有限公司, as the successful bidder for the project [1] - The contract amount for the Jiangsu Expressway Cloud Expansion Project is 43.166 million RMB [1] Group 2: Business Implications - This contract represents a routine operational contract for the company, contributing to its ongoing business activities [1]

格隆汇12月24日丨通行宝(301339.SZ)公布，近日，江苏高速公路联网营运管理有限公司（简称"江苏高 网"）以询比采购的方式，确定了江苏高网2025年高速云扩容项目的成交人为江苏通行宝智慧交通科技 股份有限公司控股子公司南京感动科技有限公司（简称"感动科技"）。依据上述中标结果，双方签署了 《江苏高网2025年高速云扩容项目合同》，本合同金额为4,316.60万元人民币，为公司日常经营性合 同。 ...

每经AI快讯，通行宝（SZ 301339，收盘价：14.48元）12月24日晚间发布公告称，近日，江苏高速公路 联网营运管理有限公司（以下简称"江苏高网"）以询比采购的方式，确定了江苏高网2025年高速云扩容 项目的成交人为江苏通行宝智慧交通科技股份有限公司（以下简称"公司"）控股子公司南京感动科技有 限公司（以下简称"感动科技"）。依据上述中标结果，双方签署了《江苏高网2025年高速云扩容项目合 同》（以下简称"本合同"），本合同金额为4316.60万元人民币，为公司日常经营性合同。 感动科技为公司控股子公司，江苏高网持有公司20.77%的股份，属于与公司受江苏交通控股有限公司 同一控制下的关联方，且江苏高网总经理张西亚先生兼任公司董事。根据《深圳证券交易所创业板股票 上市规则》相关规定，本次交易构成关联交易。 截至发稿，通行宝市值为84亿元。 每经头条（nbdtoutiao）——左手"欠款"右手"豪购"！杨陵江收购"国内酒庄第一股"，1919是否重启上 市？"吹太多牛都实现了，但千亿还没实现，我很着急" （记者 王晓波） 2025年1至6月份，通行宝的营业收入构成为：软件和信息技术服务业占比100.0%。 ...

Core Viewpoint - The company announced a contract worth 43.166 million yuan for the Jiangsu Highway Cloud Expansion Project, which is expected to positively impact its operating performance [1] Group 1: Contract Details - The contract was signed between the company's subsidiary, Nanjing Gando Technology Co., Ltd., and Jiangsu Highway Network Operation Management Co., Ltd. [1] - The contract amount is 43.166 million yuan [1] - This transaction is classified as a related party transaction and does not constitute a major asset reorganization, nor does it require approval from relevant authorities [1] Group 2: Impact on Performance - The execution of the contract is anticipated to have a positive effect on the company's operating results [1]